Videos

DAIC Thought Leadership Series: The Importance of Inclusion in Clinical Trials

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits down with Philip B. Adamson, MD, MSc, FACC, Chief Medical Officer of CVRx, to talk about health equity — starting at the beginning of clinical trials, and including how medical device manufacturers need a clear roadmap from the get-go to achieve success.

As Chief Medical Officer of CVRx, Dr. Adamson will spearhead efforts to drive awareness and appropriate use of Barostim therapy among clinicians. He will guide comprehensive medical education, outreach and guideline integration initiatives to establish Barostim as the standard of care for patients with heart failure. Dr. Adamson previously was with Abbott Laboratories, where he served as Divisional Vice President and Chief Medical Officer of the Heart Failure division. A renowned expert in heart failure, he has nearly three decades of experience in academia as a professor and as a practicing cardiologist, during which time he authored over 150 manuscripts and book chapters. Dr. Adamson earned his MD with distinction from the University of Oklahoma College of Medicine and MSc in physiology from the University of Oklahoma.

His clinical interests focus on developing more efficient and effective disease management systems for patients with chronic heart failure, specifically focusing on remote monitoring of physiologic signals from implanted devices. He has also served as the principal investigator on the steering committees of several large randomized clinical trials over the past decade.

Related content:

DAIC Thought Leadership Series: Practical Realities of Artificial Intelligence in Echocardiology

DAIC Thought Leadership Series: Collaboration Challenges in Complex Cardiology Settings

 

Recent Video

Artificial Intelligence | December 12, 2018

This is an example of how artificial intelligence (AI) can help improve patient care by pulling together patient data from numerous sources n the elect if medical records that are specific to a patient’s diagnosis and treatment for a specific disease state. This is Siemens’ AI-Pathway Companion introduced at the Radiological Society Of North America (RSNA) 2018 meeting this week. In this examples. A prostate cancer patient has all their data on a single time line that can be accessed by single clicks on the points to open reports, images, procedures or labs.

At the end of the time line it integrates AI driven clinical decision support that recommends the next course of action based on clinical guidelines. The guidelines cited can also be opened for review by the clinician.

Interventional Radiology | September 10, 2019

Scott Schwartz, M.D., interventional radiologist and program director for IR residencies and the vascular and interventional radiology fellowship at Henry Ford Hospital, explains how the department uses Yttrium-90 (Y90) embolization therapy to treat liver cancer.

Additional articles and videos on Henry Ford Hospital 

 

Related Articles on Y-90 Radiotherapy:

Current Advances in Targeted Radionuclide Therapy

A Look Ahead in Targeted Radionuclide Therapy

Radioactive Bead Therapy Now Used for Head, Neck Tumors

NCCN Guidelines Recommend Y-90 Microspheres for Metastatic Colorectal Cancer Treatment

 

(Editor's note - this video was originally published in November 2018 and was revised September 2019)

Cath Lab | November 15, 2018

Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and feasibility randomized controlled trial, presented as a late-breaking study at the 2018 American Heart Association meeting. Learn more at ProtectedPCI.com/DAIC.

 

Related Impella Video Content:

VIDEO: Complex PCI Involving Prior CABG and Comorbidities — Interview with Perwaiz Meraj, M.D.

VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device — Interview with William O'Neill, M.D.

VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael Amponsah, M.D.,

 

 

Heart Failure | November 15, 2018

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at Mass General Hospital,, Boston, spoke at the 2018 American Heart Association (AHA) meeting about blood biomarkers that can aid in assessing reverse remodeling in heart failure patients with reduced ejection fraction (HFrEF). 

Januzzi mentions the use of high sensitivity troponin in this video. Watch a VIDEO interview with Januzzi on his research with high sensitivity troponin.

 

 

EP Lab | November 15, 2018

Wilber Su, M.D., chief of cardiac electrophysiology, Banner University Medical Center, Phoenix, and clinical associate professor of medicine at the University of Arizona, explains the Heart Rhythm Society (HRS) best practices document on cryoballoon ablation. He led the development of that document. He spoke at the 2018 American Heart Association (AHA) meeting.

Read the HRS "Best practice guide for cryoballoon ablation in atrial fibrillation: The compilation experience of more than 3,000 procedures."

Read the related article "New Technologies to Improve Atrial Fibrillation Ablation."

 

 

Artificial Intelligence | November 14, 2018

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at  Mass General Hospital, Boston, spoke at the 2018 American Heart Association (AHA) meeting about his use of artificial intelligence to data-mine patient records. He spoke at AHA on the use of an AI-driven model to predict acute kidney injury (AKI) in patients undergoing coronary angiography, and on the results from a catheter sampled blood archive in a cardiovascular disease study.

Read the related article "How Artificial Intelligence Will Change Medical Imaging."

 

 

 

Computed Tomography (CT) | November 14, 2018

Matthew Budoff, M.D., professor of medicine, David Geffen School of Medicine, UCLA, spoke at the 2018 American Heart Association (AHA) meeting on the new AHA guidelines for cholesterol, including the use of computed tomography (CT) calcium scoring scans to assess patient risk. Budoff has been involved in several of the coronary artery calcium (CAC) trials that supported the new recommendation.

 

 

Related CT Calcium Scorining Content:

VIDEO: New Cholesterol Guidelines Support CT Calcium Scoring for Risk Assessment — Interview with Matthew Budoff, M.D.

CT Calcium Scoring Becoming a Key Risk Factor Assessment

ACC and AHA Release Updated Cholesterol Guidelines for 2018

VIDEO: CT Calcium Scoring to Screen For Who Should Take Statins — Interview with Matthew Budoff, M.D.

VIDEO: The History of CT Calcium Scoring — Interview with Arthur Agatston, M.D.

 

 

 

Pharmaceuticals | November 13, 2018

Deepak L. Bhatt, M.D., executive director of the interventional cardiovascular program, Brigham and Women’s Hospital Heart & Vascular Center and Harvard Medical School, explains the results of the late-breaking REDUCE-IT Trial at the 2018 American Heart Association (AHA) meeting. This is a landmark study that showed icosapent ethyl (Vascepa) can significantly reduce major adverse cardiac and stroke events in patients with continued high triglyceride levels while on statin therapy.

Read the article on the REDUCE-IT Trial

Hypertension | November 07, 2018

Kim Allan Williams, Sr., M.D., chief of the Division of Cardiology and the James B. Herrick Professor at Rush University Medical Center, discusses the efforts being made by the Association of Black Cardiologists to reduce systemic hypertension in the African-American community. Williams is speaking on this topic at the American Heart Association 2018 meeting.

 

 

Cath Lab | November 07, 2018

In 2009, the GuideLiner Catheter revolutionized the concept of guide extension, creating new possibilities in interventional cardiology. Now in its third generation, the GuideLiner V3 Catheter continues to build on a history of innovation and performance — one that has been demonstrated with more than half a million catheters in cath labs around the world.

Teleflex also offers a family of Turnpike Catheters. These contain a robust multi-layer shaft that provides impressive flexibility, torque and tracking over a 0.014” guidewire in complex coronary and peripheral interventions. The unique five-layer composite shaft provides an ideal combination of flexibility and torque response to help navigate through complex anatomy while the outer polymer layer paired with a 60 cm distal hydrophilic coating facilitates smooth catheter delivery. This portfolio consists of the Turnpike Catheter (standard version), the Turnpike Spiral Catheter, the Turnpike Gold Catheter, and the Turnpike LP Catheter. Each catheter configuration contains a specific design element to address various clinical challenges in complex procedures

This year, Teleflex acquired two well-known PTCA balloon catheters. The Chocolate XD PTCA Balloon Catheter is a specialty angioplasty balloon, used in the pre-dilatation and treatment of coronary lesions. The balloon’s proprietary nitinol constraining structure creates “pillows” and “grooves” that are designed to provide controlled dilatation while minimizing vessel wall trauma.

The Glider PTCA Balloon Catheter is a semi-compliant balloon with a skived tip and low entry profile. The tip design, coupled with hydrophilic coating and an innovative, torqueable shaft, allows for precise tip orientation for use in crossing complex lesions and stent struts.

For more information: www.teleflex.com

Congenital Heart | November 01, 2018

Example of GE Healthcare’s FetalHQ software for the ultrasound imaging of fetal hearts. The new tool runs on GE Healthcare’s Voluson ultrasound systems and is the first tool to simultaneously examine the size, shape and function of the fetal heart echocardiography for congenital heart evaluations.

Read more about the technology in the article "Cardiac Ultrasound Software Streamlines Fetal Heart Exams."

 

 

Cath Lab | October 24, 2018

Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic support with the Impella 2.5 heart pump during high-risk PCI can reduce the risk of AKI even when those patients had pre-existing kidney disease and a low ejection fraction. For more information: http://bit.ly/2Pfaqxh

 

Related Impella Video Content:

VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device — Interview with William O'Neill, M.D.

VIDEO: The Door-to-Unloading (DTU) STEMI Safety and Feasibility Trial — Interview with Navin Kapur, M.D.

VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael Amponsah, M.D.

VIDEO: Complex PCI Involving Prior CABG and Comorbidities — Interview with Perwaiz Meraj, M.D.

 

October 11, 2018

Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific, explains key trial data presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference. He also explained the company's recent purchase of numerous start-up companies to expand in areas of structural heart, venous interventions, electrophysiology and oncology. 

Hear Meredith's insights in the VIDEO: Future Research and Development Efforts in Cardiovascular Medicine

 

October 11, 2018

A discussion with Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific, on future directions for cardiology device technology development. He spoke to DAIC at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference.

Hear Meredith's insights in the VIDEO: Boston Scientific's Recent Cardiology Advances and Technology Acquisitions

TCT | October 03, 2018

DAIC Editor Dave Fornell takes a tour of some of the most innovative new cardiovascular technology he found on the expo floor at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference.

Here are links to other Editor's Choice videos at recent conferences:

VIDEO: Editor's Choice of Most Innovative New Cardiac Technology at ACC 2018

VIDEO: Editor’s Choice of the Most Innovative Echo Technology at ASE 2018

VIDEO: Editor's Choice of the Most Innovative New Imaging Technology at RSNA 2017

 

 

#TCT2018

Womens Cardiovascular Health | October 01, 2018

Cindy Grines, M.D., chair and professor, department of cardiology, Zucker School of Medicine, Hostra/Northwell, spoke on this topic in sessions at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference. 

 

Related Women's Heart Health Content:

VIDEO: Sex Differences in Diagnosing Heart Disease in Women — Interview with Doreen DeFaria Yeh, M.D.

Cindy Grines Becomes SCAI President

VIDEO: How to Build a Successful Women’s Heart Center — Interview with Malissa Wood, M.D.

VIDEO: Creating a Cardio-Obstetrics Team — Doreen DeFaria Yeh, M.D.

Diagnostic Differences in Women’s Heart Health

Find more articles on women's heart issues in the Women's Cardiovascular Health channel

Left Atrial Appendage (LAA) Occluders | October 01, 2018

Ashish Pershad, M.D., medical director, structural heart program, Banner University Medical Heart Institute, Phoenix, explains the difference he found between the FDA cleared Watchman left atrial appendage (LAA) occluder and the Abbott Amplatzer Amulet device now in U.S. trials. He spoke on these differences at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference. 

Watch the VIDEO: New Data on LAA Occlusion From the PREVAIL and PROTECT Trials — Interview with Vivek Reddy, M.D.

Read the article "Occluding the Left Atrial Appendage (LAA)."

#TCT2018

Hemodynamic Support Devices | October 01, 2018

Nevin Kapur, M.D., FAHA, FACC, FSCAI, executive director, Cardiovascular Center for Research and Innovation, Tufts Medical Center, Boston, explains the importance of ventricular unloading in the management of acute myocardial infarction and cardiogenic shock. He spoke on this topic at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference. 

 

Related Cardiogenic Shock Content:

New Approaches to Reduce Cardiogenic Shock Mortality

10 Reasons Why it is Time to Learn More About Cardiogenic Shock

VIDEO: How to Reduce Cardiogenic Shock Mortality by 50 Percent

Hemostasis Management | September 27, 2018

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morristown Medical Center, part of Atlantic Health System, explains some of the technologies and techniques to close large vascular access sites due to TAVR, TEVAR and hemodynamic support devices. He was involved in a session on this topic at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference. 

Read more about vascular closure devices.

 

#TCT2018

 

 

Artificial Intelligence | September 27, 2018

Rami Doukky, M.D., professor of medicine, preventative medicine and radiology, and chief of the Division of Cardiology at Cook County Health and Hospitals System, discusses how artificial intelligence (AI) will impact all medical imaging modalities at the 2018 American Society of Nuclear Cardiology (ASNC) annual meeting in San Francisco.

 

Related Artificial Intelligence Content in Cardiac Imaging:

VIDEO: Artificial Intelligence in Cardiac Ultrasound — Interview with Partho Sengupta, M.D.

How Artificial Intelligence Will Change Medical Imaging

Combatting the World’s No. 1 Cause of Death With the Help of Artificial Intelligence and Advanced Technology

Advances in Cardiac Imaging Technologies at RSNA 2017
 

 

 

September 27, 2019

Akshay Khandelwal, M.D., director of medical operations at the Henry Ford Heart and Vascular Institute, Detroit, and associate professor of cardiology at Wayne State University, explains how his center has reduced X-ray radiation dose in the cardiac catheterization labs.

Watch the related VIDEO: Reducing Cath Lab Radiation Dose at Henry Ford Hospital — Discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS, Henry Ford Hospital.

Additional articles and videos on Henry Ford Hospital 

 

For more on how to reduce dose in the cath lan, read these related articles:

Cardiology Societies Call for Better Radiation Dose Tracking

Defining the Cath Lab Workplace Radiation Safety Hazard

Dose-Lowering Practices for Cath Lab Angiography

5 Technologies to Reduce Cath Lab Radiation Exposure

VIDEO: Heart Surgeon Shares Effects of Fluoroscopic Radiation Exposure

Helping Interventional Cardiologists Reduce Exposure to Ionizing Radiation

14 Ways to Reduce Radiation Exposure in the Cath Lab

 

(Editor's note - this video was originally published in November 2018 and was revised September 2019)

 

Intravascular Imaging | September 26, 2018

Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular research and advanced education, Medstar Heart Institute, explains details of the late-breaking LRP (Lipid Rich Plaque) Trial at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference. The trial used near infrared spectroscopy (NIRS) combined with intravascular ultrasound (IVUS) to identify vulnerable plaques and track them over time to determine the accuracy of the risk assessment. He said this may be a paradigm shift for interventional cardiology, being able to identify high-risk lesions before they cause a heart attack.

Read the article on the LRP Study reults.

Learn more about the LRP study in another VIDEO with Waksman at ACC 2018.

Find more news and video from TCT.

 

 

#TCT2018

 

 

 

 

 

Cath Lab | September 19, 2018

William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) database. Learn more at ProtectedPCI.com.

Stents | September 11, 2018

This is an animation showing how the dedicated bifurcation stent developed by Advanced Bifurcation Systems (ABS) is deployed in coronary vessels. The vendor made its debute on the expo floor of the 2018 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. The ABS system is in the process of obtaining regulatory approval and no products are currently for sale.

Hemodynamic Support Devices | August 31, 2018

Behnam Tehrani, M.D., FSCAI, director of the cardiac cath lab, INOVA Heart and Vascular Institute, Fairfax, Va., discusses a complex, high-risk percutaneous coronary intervention (PCI) case where hemodynamic support from an Abiomed Impella device is used to support the patient. 

Visit ProtectedPCI.com for more video cases. The website also has additional information on protocols for protected PCI and cardiogenic shock hemodynamic support.

Watch a VIDEO demonstration of how the Impella percutaneous hemodynamic support pump works.

 

 

 

Nuclear Imaging | August 22, 2018

Kim A. Williams, Sr., M.D., MACC, MASNC, FAHA, FESC, cardiology division chief and James B. Herrick professor at Rush University Medical Center, discusses the importance of nuclear cardiology in preventive medicine, and previews his upcoming keynote lecture at the 2018 annual meeting of the American Society of Nuclear Cardiology (ASNC), Sept. 6-9 in San Francisco.

Watch the related VIDEO ASNC 2018 Program Preview, where Rami Doukky, M.D., professor of medicine, preventive medicine and radiology, and chief of the Division of Cardiology at Cook County Health and Hospitals System, discusses new additions to the ASNC meeting program for 2018.

Watch the VIDEO MACRA's Impact on Cardiology, an interview with Williams on the impact of healthcare reform on cardiology and specifically on nuclear perfusion imaging.

Nuclear Imaging | August 21, 2018

Rami Doukky, M.D., professor of medicine, preventive medicine and radiology, and chief of the Division of Cardiology at Cook County Health and Hospitals System, discusses new additions to the program for the 2018 annual meeting of the American Society of Nuclear Cardiology (ASNC), Sept. 6-9 in San Francisco.

Watch the VIDEO: Imaging in the Assessment of Preventive Cardiology — interview with Kim Williams, M.D., about his key note lecture at the 2018 ASNC.

Watch the VIDEO: American Society of Nuclear Cardiology (ASNC) Celebrates 25 Years — interview with Robert C. Hendel, M.D.

Watch the VIDEO Clinical Decision Support Requirements for Cardiac Imaging, an interview with Doukky at the 2017 ASNC Today meeting.

Cardiac Imaging | September 10, 2018

Leslee Shaw, Ph.D., professor of cardiology and radiology, Weill Cornell Medical Center, New York, and past-president of the Society of Cardiovascular Computed Tomography (SCCT), explains how cardiac imaging will be used in the ISCHEMIA Trial to assess treatment strategies for patients with stable ischemic heart disease. The trial was discussed by Shaw at the 2018 American Society of Nuclear Cardiology (ASNC) meeting.

Watch the related VIDEO Role of Cardiac CT in Value-based Medicine, an interview with Shaw at SCCT 2017.

Cath Lab | August 13, 2018

Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascular Hospital, Dallas, explains some of the key innovations his institution is using to improve cardiovascular care. These include the use of robotic percutaneous coronary intervention (PCI), FFR-CT imaging and transcatheter valve technologies.

Take a 360 photo look inside a Baylor combo cardiac cath/EP lab. 

Watch the VIDEO: Dedicated Cardiac MRI Use at the Baylor Scott White Heart Hospital — an interview with Haojie Wang, M.D., director of advanced cardiovascular MRI and a member of the heart valve clinic at Baylor Scott White Heart Hospital, Dallas.

 

 

Magnetic Resonance Imaging (MRI) | August 13, 2018

Haojie Wang, M.D., director of advanced cardiovascular MRI and a member of the heart valve clinic at Baylor Scott White Heart Hospital, Dallas, explains the utility of magnetic resonance imaging (MRI) in cardiology and the implementation of the cardiac MRI program at his hospital.

See a 360 degree photo of the Baylor MRI control room.

Watch the VIDEO: Implementation of New Cardiovascular Technologies at Baylor Scott White Heart Hospital — interview with Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascular Hospital, Dallas.
 

Watch the VIDEO: Advances in Cardiac MRI Technology — Interview with James Carr, M.D.

Stents Bioresorbable | August 06, 2018

Patrick Serruys, M.D., Ph.D., Imperial College London, explains where development of bioresorbable scaffolds stands in 2018. He spoke to DAIC at the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting. 

Watch the related VIDEO What Went Wrong With the Absorb Stent?

Read the related article Current State of Bioresorbable Stent Technology

Read the related article Amaranth Unveils 85-micron Bioresorbable Stent

 

ASNC | July 25, 2018

Robert C. Hendel, M.D., FACC, FAHA, MASNC, director, Tulane Heart and Vascular Institute, explains the impact the ASNC has had on cardiac nuclear imaging during this anniversary year. 

The Annual Scientific Session of the American Society of Nuclear Cardiology is Sept. 6-9, 2018, at the San Francisco Marriott Marquis.

#ASNC2018

Computed Tomography (CT) | July 25, 2018

A discussion with Patricia Dickson, LRT(CT), director of imaging and outpatient services, Capital Cardiology Associates, Albany, N.Y., and Nikki Weber, RT(R)(CT)(M), a lead CT technologist at the Mayo Clinic, Rochester, Minn. They presented in sessions at the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting.

 

Related Tips to Improve CT Imaging Content:

VIDEO: Tips and Tricks to Aid Cardiac CT Technologist Workflow

VIDEO: How to Prepare a Patient for a Cardiac CT Scan

VIDEO: 10 Tips to Improve Cardiac CT Imaging

Find more SCCT news and videos

 

Computed Tomography (CT) | July 23, 2018

Ed Nicol, M.D., FSCCT, MBA, head of cardiac CT, Royal Brompton Hospital, London, and chair of the Society of Cardiovascular Computed Tomography (SCCT) Education Committee. He outlined new initiatives by SCCT to expand its educational offerings. For more information on SCCT's online educational links go to https://scct.org/page/Education.

Link to the technologist video referenced in this interview that is among the most viewed videos on DAIC — VIDEO: How to Prepare a Patient for a Cardiac CT Scan.

CT Angiography (CTA) | July 19, 2018

Kavitha Chinnaiyan, M.D., FACC, FSCCT, associate professor, Oakland University, William Beaumont School of Medicine, Royal Oak, Mich. She presented at the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting. 

She explains how noninvasive fractional flow reserve computed tomography (FFR-CT) is being used at Beaumont to assess patients presenting with chest pain. FFR-CT has been used to triage these patients faster than doing a series of troponin tests, keeping patients overnight for a nuclear scan or sending them for a diagnostic angiogram. Most patients can be discharge is a fraction of the time compared to these other standards of care. Chinnaiyan also showed examples of FFR-CT, CT angiograms and cath lab invasive angiograms of the same lesions to show the correlation between the different modalities. Some examples show what appears to be a severe lesion, but FFR-CT shows acceptable blood flow past lesions so no revascularization was required.

 

Related FFR-CT Content:

Clinical Applications of FFR-CT

VIDEO: Implementation and the Science Behind FFR-CT — interview with James Min, M.D.

VIDEO: Early U.S. Experience With FFR-CT in Evaluating ED Chest Pain Presentation — interview with Simon Dixon, M.D.

VIDEO: Status of FFR-CT Adoption in the United States — interview with Campbell Rogers, M.D.

 

July 18, 2018

Suhny Abbara, M.D., FSCCT, chief of cardiothoracic imaging and chair of the CT operations committee, University of Texas Southwestern Medical Center, Dallas, incoming president of the Society of Cardiovascular Computed Tomography (SCCT), and editor of the new RSNA journal Radiology: Cardiothoracic Imaging. He spoke to DAIC at SCCT 2018 meeting. 

Read the related article "Spectral Imaging Brings New Light to CT."

 

 

CT Angiography (CTA) | July 18, 2018

A discussion with Gianluca Pontone, M.D., Ph.D., FSCCT, director of cardiovascular MRI, Centro Cardiologico Manzino, Milan, Italy, at the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting. He said CT can be comparable to the gold-standards of nuclear and MRI perfusion depending on the scanner used to acquire the images. 

Read the article "CT Perfusion Imaging Ready for Mainstream." 

Heart Valve Technology | July 18, 2018

Jonathon Leipsic, M.D., FSCCT, professor of radiology and cardiology at the University of British Columbia, Vancouver, Canada, and an expert in transcatheter valve imaging. He spoke about his experiences with TAVR and TMVR trials and devices planning at the the Society of Cardiovascular Computed Tomography (SCCT) 2018 meeting.

Read the related article "The Essentials of Structural Heart Imaging."

Watch the VIDEO "What to Look for in CT Structural Heart Planning Software."
 

 

 

Subscribe Now